Paliperidone Tablet, Film Coated, Extended Release
Product Images NDC 47335-765

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paliperidone (NDC 47335-765). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-paliperidone1-5mg (Spl Paliperidone1 5mg)

Label for Paliperidone Extended-Release Tablets 1.5 mg, film-coated, extended-release tablets by Sun Pharmaceutical Industries, Inc. The label indicates the tablets should be swallowed whole, not divided, crushed, or chewed, and taken once daily. The package contains 30 tablets and is prescription only.*

FDA Label Image

Spl-paliperidone3mg (Spl Paliperidone3mg)

Label for Paliperidone Extended-Release Tablets 3 mg, film-coated tablets supplied in a bottle of 30 tablets. The label includes directions that the tablets should be swallowed whole and taken once daily. It is labeled for Rx only and manufactured by Sun Pharmaceutical Industries, Inc.*

FDA Label Image

Spl-paliperidone6mg (Spl Paliperidone6mg)

Label for Paliperidone Extended-Release Tablets 6 mg by Sun Pharmaceutical Industries, Inc. The label indicates 30 tablets in the package, with instructions to swallow whole and not to divide, crush, or chew. It also states the tablets should be taken once daily.*

FDA Label Image

Spl-paliperidone9mg (Spl Paliperidone9mg)

Label for Paliperidone Extended-Release Tablets, 9 mg strength, oral extended-release film-coated tablets. The label states the tablets should be swallowed whole and taken once daily. Pack contains 30 tablets. Labeler is Sun Pharmaceutical Industries, Inc. NDC 47335-767-83.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of the active ingredient paliperidone, showing its molecular framework with nitrogen, oxygen, fluorine atoms, and ring structures, corresponding to the paliperidone molecule used in film-coated extended-release tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.